Whitepaper: Mitochondrial toxicity assessment
This whitepaper establishes a customised XF assay solution for the detection of mitochondrial toxicity using standardised parameters.
List view / Grid view
This whitepaper establishes a customised XF assay solution for the detection of mitochondrial toxicity using standardised parameters.
Discover how the Agilent Seahorse XF Real Time ATP rate assay provides a simple robust workflow that can identify metabolic targets for drug discovery
Struggling with spontaneous differentiation? Learn about one of the biggest challenges in human pluripotent stem cell research.
Explore current insights into the clinical possibilities posed by organoids and delve into short and long-term prospects for therapeutic screening and personalised regenerative medicine in this whitepaper.
Tune into this podcast to hear experts discuss imaging and obtaining data from organoids!
Cell signalling through the Akt pathway controls numerous key cellular functions including proliferation, survival, and migration.
Researchers from the University of Pennsylvania have developed a novel organ-on-a-chip technology called OCTOPUS, an optimised device for growing mini-organs in a dish.
Cell proliferation assays are a cornerstone of cancer therapeutic, developmental biology, and drug safety research.
Discover how Catalent can help you achieve efficiencies and develop a robust, reproducible manufacturing plan for late-stage and commercial launch.
Discover the Incucyte® Scratch Wound Analysis Software Module for automated image-based measurements of cell migration in vitro, using label-free analysis.
Read about the current state of the industry, challenges associated with potency assays and measuring product potency throughout the manufacturing process.
Understand how quality control assays are being implemented in monitoring the development of CAR-T cells using high-throughput technologies in this article.
The pipetting robot, flowbot® ONE, is available with a HEPA filter to make clean-up processes easy and effective, enabling you to keep your samples safe.
UCL researchers have developed a possible new treatment for neurological and psychiatric diseases, that works by reducing the excitability of overactive brain cells.
Discover how a plasmid DNA manufacturing platform process is helpful from preclinical studies to scaling production for late-stage and commercial needs.